Floatz logo

Anakinra

Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

M.D. Anderson Cancer Centerprotein_peptidePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Axicabtagene Ciloleucel
Ruijin Hospital
Phase 4BBB
HUMAN FAECAL MATTER
City of Hope Medical Center
Phase 2CCC
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Roswell Park Cancer Institute
Phase 1CC

Same molecule, other indications

Anakinra is also rated in:

obesity disorderDormant
BB
Indicative ·
64 / 100
View asset →
hypogonadotropic hypogonadismDormant
BB
Indicative ·
64 / 100
View asset →
adrenal gland hyperfunctionDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →